Sono-Tek Corp designs and manufactures ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial, and emerging research & development/other markets... Show more
Sono-Tek Corporation (NASDAQ: SOTK) designs and manufactures precision ultrasonic coating systems that apply thin films to components across medical devices, microelectronics, alternative energy, industrial manufacturing, and research applications. As the company transitions toward larger, higher-value production platforms, investors are watching whether record clean-energy orders, sustained medical demand, and an emerging semiconductor opportunity can extend its growth trajectory into 2026 and beyond.
Sono-Tek occupies a specialized niche in ultrasonic thin-film coating, a technology prized for precision, uniformity, and reduced material waste. Its systems apply functional coatings to surfaces in applications where accuracy and repeatability are critical, from drug-eluting stents to solar cells and semiconductor packaging. The company's proprietary nozzle and generator technology, combined with application engineering expertise, creates meaningful switching costs for customers whose manufacturing processes are built around its equipment.
The most significant structural shift underway is the transition from selling relatively low-priced nozzles and laboratory systems to supplying complete, automated production lines. This evolution raises the value of each sale, improves margin quality, and deepens customer relationships. In fiscal 2026, in-line (integrated) coating systems revenue grew 91%, reflecting shipments of high-value solar production platforms. Management is also planning phased capacity expansion, targeting a path from current capabilities toward $35 million and eventually $45 million in revenue capacity, which would meaningfully expand the company's addressable output.
Competitive risks remain. The company's reliance on a concentrated set of large, high-ASP orders introduces lumpiness, and its relatively small scale compared with broader industrial equipment makers can limit pricing power in commodity segments. Nevertheless, its position as a specialist with patented technology and a diversified end-market footprint supports a defensible medium-term outlook.
Several forward-looking catalysts could shape investor sentiment. First, the execution and delivery of the record clean-energy order is a near-term focal point, as the timing of high-ASP system shipments drives quarterly revenue variability. Management has reiterated guidance for flat to modest revenue growth in fiscal 2027, explicitly attributing the conservative outlook to order timing rather than demand deterioration.
Second, the company's semiconductor initiative represents a potentially transformative opportunity. Sono-Tek is developing a 300-millimeter wafer coating system for the semiconductor fabrication (fab) market and plans to introduce the machine at Semicon Europe, with potential revenue contributions expected in fiscal 2028. A successful commercial launch would open a large, technically demanding market that could materially broaden the company's long-term growth runway.
Third, the technical collaboration with Diamond Quanta to integrate Sono-Tek's coating systems into engineered diamond-on-glass manufacturing spans semiconductor, optics, thermal, and quantum applications, offering optionality across advanced materials.
On the analyst front, consensus price targets have trended higher following the record order, with the average 12-month target around $8.50. Coverage remains limited to a small number of firms, and views diverge: Oak Ridge Financial maintains a Buy rating with an $8.50 target, while Northland Securities holds a more cautious Hold rating with a $5.00 target. This dispersion reflects genuine uncertainty about the timing and magnitude of large-order conversion.
Sono-Tek's fortunes are tied to several macro and policy dynamics. Clean-energy demand is highly sensitive to government incentives: reduced U.S. support for hydrogen electrolysis contributed to a 19% decline in the alternative-energy segment in fiscal 2026, partially offset by solar system shipments. The direction of federal and state clean-energy policy in 2026 remains a pivotal swing factor.
Interest rates and capital-spending cycles also matter. Many of Sono-Tek's customers fund equipment purchases through capital budgets or venture-backed scaling plans. A higher-for-longer rate environment can temper industrial and emerging-technology capital expenditure, though the company's debt-free balance sheet insulates it from financing costs directly. Trade policy and tariffs add another layer of complexity, given the company's meaningful international exposure across Asia Pacific and EMEA (Europe, Middle East, and Africa).
On the positive side, structural trends favor the company: the growing medical device market, the push toward localized and resilient semiconductor supply chains, and increasing demand for precision manufacturing techniques that reduce material waste all align with Sono-Tek's core value proposition.
Investors tracking the evolving outlook for Sono-Tek and similar instruments may benefit from a data-driven view of short-term direction. Tickeron's Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF (exchange-traded fund), or other asset may move bullish, bearish, or sideways over the next week or month. Designed to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments, the tool offers searchable prediction categories, historical context, and alert-oriented functionality. For those seeking an additional lens on near-term market behavior, the Trend Prediction Engine provides a structured way to monitor shifting signals alongside fundamental research.
Looking toward 2026 and beyond, Sono-Tek's trajectory hinges on its ability to convert its strategic shift into durable, higher-margin growth. Management's guidance for flat to modest fiscal 2027 revenue growth reflects a deliberately conservative posture while large orders remain in flux, but the medical segment's strength and the growing installed base of production systems provide a foundation for more consistent expansion.
Key long-term themes include the semiconductor wafer opportunity, which, if commercialized, could redefine the company's addressable market; margin sustainability as high-ASP systems become a larger share of the revenue mix; and cost-structure evolution tied to planned capacity expansion. Competitive threats from larger coating-equipment suppliers and the risk of policy-driven demand swings in clean energy remain the principal watch items.
Capital allocation will also be in focus. With a debt-free balance sheet, roughly $14.8 million in cash, and a lightly exercised buyback program, the company retains flexibility for selective acquisitions or accelerated internal investment. Consensus analyst expectations currently embed meaningful long-term revenue growth, with fiscal 2028 revenue estimates implying a notable step-up, but the timing of large orders and the pace of semiconductor adoption will determine whether those assumptions are realized.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MRA | 16.04 | 0.47 | +3.05% |
| GraniteShares Autocallable MARA ETF (MRA) | |||
| FFOG | 49.83 | 0.59 | +1.20% |
| Franklin Focused Growth ETF | |||
| NVBT | 41.20 | 0.25 | +0.62% |
| AllianzIM U.S. Equity Buffer10 Nov ETF (NVBT) | |||
| LCLG | 69.15 | 0.15 | +0.22% |
| Logan Capital Large Cap Growth ETF (LCLG) | |||
| DHS | 116.62 | -0.28 | -0.24% |
| WisdomTree U.S. High Dividend Fund (DHS) | |||
A.I.dvisor tells us that SOTK and MKSI have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SOTK and MKSI's prices will move in lockstep.
| Ticker / NAME | Correlation To SOTK | 1D Price Change % | ||
|---|---|---|---|---|
| SOTK | 100% | -1.70% | ||
| MKSI - SOTK | 25% Poorly correlated | +2.35% | ||
| ST - SOTK | 24% Poorly correlated | +0.67% | ||
| NOVT - SOTK | 23% Poorly correlated | +3.21% | ||
| VPG - SOTK | 22% Poorly correlated | +4.29% | ||
| MLAB - SOTK | 20% Poorly correlated | +3.23% | ||
More | ||||
Industry ElectronicEquipmentInstruments
SOTK's Aroon Indicator triggered a bullish signal on October 20, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 131 similar instances where the Aroon Indicator showed a similar pattern. In 104 of the 131 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 79%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The 10-day moving average for SOTK crossed bullishly above the 50-day moving average on October 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Following a +4.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where SOTK advanced for three days, in 168 of 227 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
The 10-day RSI Indicator for SOTK moved out of overbought territory on October 14, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 23 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SOTK as a result. In 84 of 108 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
The Moving Average Convergence Divergence Histogram (MACD) for SOTK turned negative on October 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 40 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.
SOTK moved below its 50-day moving average on October 20, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SOTK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
SOTK broke above its upper Bollinger Band on September 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. SOTK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 57 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.881) is normal, around the industry mean (1.792). P/E Ratio (39.154) is within average values for comparable stocks, (7.746). Projected Growth (PEG Ratio) (0.390) is also within normal values, averaging (5.470). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (3.258) is also within normal values, averaging (32.028).
The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 82 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SOTK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.